Latest filing published 06 Feb 2024 for 华仁药业, €3,726.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +3.6%Entry CN¥3.08 · Close at T+365 CN¥3.19
- +19.9%Entry CN¥3.47 · Close at T+365 CN¥4.16
- +19.7%Entry CN¥3.40 · Close at T+365 CN¥4.07
- +8.0%Entry CN¥4.25 · Close at T+365 CN¥4.59
- -7.8%Entry CN¥4.35 · Close at T+365 CN¥4.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
杨效东: trading record in brief
杨效东, listed as chief executive, appears in our data through filings on 华仁药业 shares, published by SSE / SZSE (CSRC). The record holds 8 filings, for trades running from 10 June 2021 to 6 February 2024.
No open-market sale appears; the market trades are 8 purchases worth €557k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2024, the count stands at 1 purchase and no sales.
Half of the purchases are above €11k and half below. 1 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 8 purchases show a median change of +3.4%, with the price up in 88% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 6 February 2024, the filings show an open-market purchase worth €3,726 in 华仁药业. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 杨效东
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0.7% of flowA股XSHESZSE:173000007310430660Canonical exit: 6 May 2024 (T+90)
- 10,000 shares0.9% of flowA股XSHESZSE:173000005476543360Canonical exit: 25 Jul 2022 (T+90)
- 120,000 shares10.8% of flowA股XSHESZSE:173000005470390200Canonical exit: 24 Jul 2022 (T+90)
- 40,000 shares4.0% of flowA股XSHESZSE:173000004737186000Canonical exit: 25 Nov 2021 (T+90)
- 20,000 shares2.0% of flowA股XSHESZSE:173000004552150700Canonical exit: 6 Oct 2021 (T+90)
- 20,000 shares2.0% of flowA股XSHESZSE:173000004497358720Canonical exit: 15 Sept 2021 (T+90)
- 790,000 shares78.6% of flowA股XSHESZSE:173000004486746800Canonical exit: 9 Sept 2021 (T+90)
- 10,000 shares1.0% of flowA股XSHESZSE:173000004478425860Canonical exit: 8 Sept 2021 (T+90)
8 of 8 declarations